Pomerantz Law Firm has initiated class action litigation against Quantum Biopharma Ltd., alleging that major Canadian financial institutions engaged in market manipulation schemes designed to artificially depress the company's stock price. According to the complaint, CIBC World Markets, RBC Dominion Securities, and Royal Bank of Canada utilized spoofed sell orders—a practice involving the placement of non-genuine orders intended to deceive the market—to artificially suppress Quantum's share valuation while positioning themselves to acquire shares at artificially reduced prices.
The lawsuit contends that these trading practices misled other market participants and investors regarding genuine market demand for Quantum Biopharma securities. Affected investors face specific deadlines for participating in the class action and may be eligible to recover losses incurred during the relevant trading period. The firm has noted that shareholders who sustained losses are urged to contact legal counsel promptly to preserve their rights.
This litigation represents one of several ongoing enforcement actions targeting alleged market manipulation in Canadian securities markets. Investors holding Quantum Biopharma shares during the relevant period should review the complaint details and consult with legal representatives regarding eligibility and claim procedures.